Yahoo Web Search

Sign In

Search results

  1. www.sanofiflu.comQuadrivalent Influenza Vaccines for Influenza Type A and B |...

    Sanofi offers a range of quadrivalent flu vaccines that help provide active immunization to prevent disease caused by influenza A subtype & type B viruses. Please see Important Safety Information or Prescribing Information.

  2. www.sanofi.in › dam › jcr:58280412-120c-45bf-abeb-b6331ada3632QUADRIVALENT INACTIVATED INFLUENZA VACCINE (SPLIT VIRION) I.P ......

    FluQuadri® is an inactivated quadrivalent influenza vaccine indicated for the prevention of influenza disease caused by influenza types A and B viruses contained in the vaccine. FluQuadri® is approved for use in persons 6 months of age and older.

  3. immunisationhandbook.health.gov.au › vaccines › fluquadriFluQuadri | The Australian Immunisation Handbook

    Quadrivalent inactivated influenza vaccine, split virion. Each 0.5 mL monodose pre-filled syringe contains: 15 µg haemagglutinin of each of the 4 recommended influenza virus strains; May contain traces of: formaldehyde (≤100 µg) octoxinol 9 (≤250 µg) ovalbumin (≤1 µg)

  4. apps.medicines.org.au › files › swpfluquAUSTRALIAN PRODUCT INFORMATION - FLUQUADRI INFLUENZA VIRUS ...

    FluQuadri is indicated for active immunisation of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FluQuadri is indicated for use in adults and children 6 months and older.

  5. www.sanofi.com.sg › dam › jcr:56c1d610-fdcd-47e2-97bdFluQuadriTM Quadrivalent Influenza Vaccine Types A and B ... -...

    FluQuadriTM (Quadrivalent Influenza Vaccine) is an inactivated quadrivalent influenza vaccine. indicated for active immunization for the prevention of influenza disease caused by influenza. types A and B viruses contained in the vaccine. FluQuadri is approved for use in persons 6 months of age and older. DOSAGE AND ADMINISTRATION.

  6. www.sanofi.com › en › media-roomEuropean Commission approves Supemtek® (quadrivalent ... - Sanofi

    Nov 18, 2018 · European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older. First and only recombinant influenza vaccine approved in the European Union. Contains three times more antigen than standard-dose vaccines.

  7. www.sanofiflu.com › fluzone-quadrivalent-influenza-vaccineFluzone Quadrivalent (Influenza Vaccine) for 6 Months and Older...

    Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Fluzone Quadrivalent is approved for use in persons 6 months of age and older. 1